Will significantly enhance service to researchers and institutions across China.
AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, is expanding the scope and ...
Alcami Corporation, a contract development and manufacturing organization (CDMO), has appointed pharmaceutical industry ...
The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to CUSP06, a Cadherin-6 targeting ...
Demonstrates its commitment to safeguarding sensitive information and adhering to global standards.
SK pharmteco, a global contract development and manufacturing organization (CDMO), has launched an enhanced analytical testing laboratory specifically dedicated to High Potency Active Pharmaceutical ...
Alloy Therapeutics Inc., a biotechnology ecosystem company, has joined forces with Pfizer Inc., to develop a new platform ...
To support the development of next-gen therapies, including GLP-1 drugs for diabetes and obesity.
To develop OliX’s OLX75016 candidate primarily targeting metabolic-associated steatohepatitis (MASH).
The FDA has granted Fast Track Designation to Lundbeck’s investigational drug, amlenetug, a potential new treatment option targeting Multiple System Atrophy (MSA).
The project is set to become the largest GMP temperature-controlled facility fully dedicated to the life sciences sector in ...
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback